Bumper Listing: Mukka Proteins Lists At 43% Premium From IPO Price On Exchanges; Should You Buy?

Mukka Proteins, a leading fish protein products manufacturer, made a stellar debut on the stock exchanges as its shares were listed at Rs 40 per share, commanding a premium of 42.86% over its initial public offering (IPO) price of Rs 28 per share. While the listing was strong, it fell short of the market's expectations for a triple-digit premium, as suggested by the grey market premium.

The IPO, which received a robust response, was oversubscribed 136.99 times. Non-institutional investors took the lead, subscribing a staggering 250.38 times their allotted quota of shares. Qualified institutional buyers followed closely, with a subscription rate of 189.28 times, while retail investors bid 58.52 times the portion set aside for them.

Analysts, maintaining a bullish stance on Mukka Proteins, cited the company's robust customer base, strong industry positioning, significant market share, and healthy financial performance in recent years as key factors driving investor confidence in the IPO.

Mukka Proteins, known for selling its products both domestically and across more than 10 countries, has consistently delivered impressive financial results. In the fiscal year 2023, the company reported a remarkable 84% year-on-year growth in net profit, reaching Rs 47.5 crore. Revenue from operations also witnessed a substantial uptick, surging by 53% to Rs 1,177.1 crore.

The company successfully raised Rs 224 crore through the IPO, with the entire amount allocated as a fresh issue of shares. Mukka Proteins plans to utilize the proceeds to bolster its working capital requirements and those of its affiliate, Ento Proteins. Additionally, the funds will be allocated towards fulfilling general corporate objectives.

Mukka Proteins' strong market debut underscores investor confidence in the company's growth potential and its strategic initiatives to fortify its market position. While the debut premium fell short of triple digits, the listing at Rs 40 per share marks a promising start for the fish protein products manufacturer in the public market.

Market analysts believe that Mukka Proteins' expansion plans and continued focus on quality products have positioned the company for sustained success. The strong response to the IPO further indicates a positive sentiment among investors, signalling a potential upward trajectory for the company's stock in the coming months.

Disclaimer: The opinions and suggestions provided above represent the views of individual analysts and do not reflect those of GoodReturns or the author. We recommend investors consult with certified experts before making any investment decisions.